Matthew R Narlesky
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Formerly Arkansas Affiliated with Harding University, UA Fort Smith through 2022; recent publications list Dartmouth–Hitchcock Medical Center.
Unknown Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Matthew R. Narlesky's research has focused on psychopharmacology and mental health interventions, with recent publications examining the use of psilocybin for psychiatric disorders and the management of attention deficits in Smith-Magenis syndrome. He has also investigated psychotropic treatment initiation in patients with specific medical conditions like Alpha-Gal syndrome and explored presentations of denial of pregnancy. Narlesky's work includes a systematic review on the safety profile of psilocybin in psychiatric treatment. His scholarship metrics include an h-index of 3, with 6 total publications and 60 total citations. He has collaborated with researchers at Harding University Main Campus, including Fahim Rasul, Suporn Braaten, and Robert G. Wooten, each sharing one publication.
Metrics
- h-index: 3
- Publications: 6
- Citations: 60
Selected Publications
-
Initiating Psychotropic Treatment in a Patient With Alpha-Gal Syndrome (2022)
-
Management of Attention Deficits and Behavioral Dyscontrol With an Evening-Dosed Methylphenidate Formulation in Smith-Magenis Syndrome (2022)
-
Denial of Pregnancy in a Patient With a History of Pseudocyesis (2021)
-
A Case of Major Depressive Disorder With Peripartum Onset With Heralding Symptoms (2020)
Collaboration Network
Top Collaborators
- Denial of Pregnancy in a Patient With a History of Pseudocyesis
- Initiating Psychotropic Treatment in a Patient With Alpha-Gal Syndrome
- Management of Attention Deficits and Behavioral Dyscontrol With an Evening-Dosed Methylphenidate Formulation in Smith-Magenis Syndrome
- Initiating Psychotropic Treatment in a Patient With Alpha-Gal Syndrome
- Management of Attention Deficits and Behavioral Dyscontrol With an Evening-Dosed Methylphenidate Formulation in Smith-Magenis Syndrome
- Initiating Psychotropic Treatment in a Patient With Alpha-Gal Syndrome
- Denial of Pregnancy in a Patient With a History of Pseudocyesis
- Denial of Pregnancy in a Patient With a History of Pseudocyesis
- Denial of Pregnancy in a Patient With a History of Pseudocyesis
- Management of Attention Deficits and Behavioral Dyscontrol With an Evening-Dosed Methylphenidate Formulation in Smith-Magenis Syndrome
- Management of Attention Deficits and Behavioral Dyscontrol With an Evening-Dosed Methylphenidate Formulation in Smith-Magenis Syndrome
- Initiating Psychotropic Treatment in a Patient With Alpha-Gal Syndrome
Similar Researchers
Based on overlapping research topics